About the Study

With the Reproductive Health After Cancer Diagnosis and Treatment (REACT) Study, we hope to gather valuable information from individuals like you that will help us to better understand the highest needs and concerns related to reproductive health—specifically for individuals diagnosed with a cancer before age 50.

The cancer experience among adults diagnosed between ages 18 and 49 years (early-onset) is unique. This is because the clinical management of these cancers is comparatively more demanding than that for cancer diagnosed in individuals age 50+ years. Among young patients, there is a greater need to treat the whole patient for whom multiple life domains are significantly impacted by the cancer diagnosis. This care is essential over time—from diagnosis and treatment to surveillance and survivorship timepoints.

Study Details

The REACT Study was a national crowdsourcing study in cooperation with twenty-three foundations/organizations.

Individuals diagnosed with a first primary cancer between the ages of 18 and 49 years were recruited over an 8-week period (October to December 2021) to participate in the REACT Study.

Patients answered sociodemographic, cancer and cancer impact/quality of life, reproductive health and fertility, sexual health, and energy balance questions via a secure, web-based REDCap application.

REACT Study Webpage/Survey:

Ethical Approval

The study was developed at the Vanderbilt University Medical Center and was approved by the Vanderbilt University Institutional Review Board (IRB# 211691).